The second webinar that the Substance Abuse and Mental Health Services Administration (SAMHSA) presented on the new methadone regulations for opioid treatment programs (OTPs) focused on clinical issues. ADAW covered the first, about administrative issues, in the last issue (see https://onlinelibrary.wiley.com/doi/full/10.1002/adaw.34089 ). In this issue, we cover part 1 of the second webinar, held on March 27.
No takes yet. Share an insight, caveat, or question.
Alison Knopf (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: